Literature DB >> 24323132

Prostate cancer: Localized disease-are most men really suitable for focal therapy?

Ben Challacombe1, Luke Dixon1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24323132     DOI： 10.1038/nrurol.2013.297

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  The index lesion and the origin of prostate cancer.

Authors:  Hashim Uddin Ahmed
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

2.  Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens.

Authors:  E David Crawford; Kyle O Rove; Al B Barqawi; Paul D Maroni; Priya N Werahera; Craig A Baer; Hari K Koul; Cory A Rove; M Scott Lucia; Francisco G La Rosa
Journal:  Prostate       Date:  2012-11-20       Impact factor: 4.104

3.  Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: a comparison with radical prostatectomy specimens.

Authors:  Andrew S Y Huo; Tania Hossack; James L P Symons; Ruth PeBenito; Warick J Delprado; Phillip Brenner; Phillip D Stricker
Journal:  J Urol       Date:  2012-04-11       Impact factor: 7.450

4.  Quality of life and satisfaction with outcome among prostate-cancer survivors.

Authors:  Martin G Sanda; Rodney L Dunn; Jeff Michalski; Howard M Sandler; Laurel Northouse; Larry Hembroff; Xihong Lin; Thomas K Greenfield; Mark S Litwin; Christopher S Saigal; Arul Mahadevan; Eric Klein; Adam Kibel; Louis L Pisters; Deborah Kuban; Irving Kaplan; David Wood; Jay Ciezki; Nikhil Shah; John T Wei
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

5.  High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.

Authors:  Benjamin J Challacombe; Declan G Murphy; Rhana Zakri; Declan J Cahill
Journal:  BJU Int       Date:  2009-02-11       Impact factor: 5.588

6.  Morbidity of focal therapy in the treatment of localized prostate cancer.

Authors:  Eric Barret; Youness Ahallal; Rafael Sanchez-Salas; Marc Galiano; Jean-Marc Cosset; Pierre Validire; Petr Macek; Matthieu Durand; Dominique Prapotnich; François Rozet; Xavier Cathelineau
Journal:  Eur Urol       Date:  2012-12-13       Impact factor: 20.096

7.  Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.

Authors:  Hashim U Ahmed; Richard G Hindley; Louise Dickinson; Alex Freeman; Alex P Kirkham; Mahua Sahu; Rebecca Scott; Clare Allen; Jan Van der Meulen; Mark Emberton
Journal:  Lancet Oncol       Date:  2012-04-17       Impact factor: 41.316

8.  Prostate cancer tumour features on template prostate-mapping biopsies: implications for focal therapy.

Authors:  Paras B Singh; Chukwuemeka Anele; Emma Dalton; Omar Barbouti; Daniel Stevens; Pratik Gurung; Manit Arya; Charles Jameson; Alex Freeman; Mark Emberton; Hashim U Ahmed
Journal:  Eur Urol       Date:  2013-10-06       Impact factor: 20.096

9.  Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.

Authors:  Wennuan Liu; Sari Laitinen; Sofia Khan; Mauno Vihinen; Jeanne Kowalski; Guoqiang Yu; Li Chen; Charles M Ewing; Mario A Eisenberger; Michael A Carducci; William G Nelson; Srinivasan Yegnasubramanian; Jun Luo; Yue Wang; Jianfeng Xu; William B Isaacs; Tapio Visakorpi; G Steven Bova
Journal:  Nat Med       Date:  2009-04-12       Impact factor: 53.440
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.